Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design.
Stewart Coats AJ, Srinivasan V, Surendran J, Chiramana H, Vangipuram SR, Bhatt NN, Jain M, Shah S, Ali IA, Fuang HG, Hassan MZ, Beadle J, Tilson J, Kirwan BA, Anker SD; on behalf of the ACT-ONE Trial Investigators. Stewart Coats AJ, et al. Among authors: jain m. J Cachexia Sarcopenia Muscle. 2011 Dec;2(4):201-207. doi: 10.1007/s13539-011-0046-2. Epub 2011 Oct 16. J Cachexia Sarcopenia Muscle. 2011. PMID: 22207908 Free PMC article.
Daratumumab in Indian patients with relapsed and refractory multiple myeloma: a prospective, multicenter, phase IV study.
Kumar L, Melinkeri S, Ganesan P, Kumar J, Biswas G, Kilara N, Pathalingappa H, Prasad S, Jain M, Mishra SK, Prasad S, Boyella PK, Sahoo RK, Bondarde S, Shah S, Rege M, Deb U, Korde T, Dixit J. Kumar L, et al. Among authors: jain m. Future Oncol. 2024 Feb;20(4):191-205. doi: 10.2217/fon-2023-0842. Epub 2023 Dec 20. Future Oncol. 2024. PMID: 38116642 Clinical Trial.
A phenome-wide association study of methylated GC-rich repeats identifies a GCC repeat expansion in AFF3 associated with intellectual disability.
Jadhav B, Garg P, van Vugt JJFA, Ibanez K, Gagliardi D, Lee W, Shadrina M, Mokveld T, Dolzhenko E, Martin-Trujillo A, Gies SJ, Altman G, Rocca C, Barbosa M, Jain M, Lahiri N, Lachlan K, Houlden H, Paten B; Genomics England Research Consortium; Project MinE ALS Sequencing Consortium; Veldink J, Tucci A, Sharp AJ. Jadhav B, et al. Among authors: jain m. Nat Genet. 2024 Sep 23. doi: 10.1038/s41588-024-01917-1. Online ahead of print. Nat Genet. 2024. PMID: 39313615
Prospective assessment of quality of life and patient-reported toxicities over the first year after CAR T-cell therapy.
Hoogland AI, Barata A, Li X, Irizarry-Arroyo N, Jain MD, Welniak T, Rodriguez Y, Oswald LB, Gudenkauf LM, Chavez JC, Khimani F, Lazaryan A, Liu HD, Nishihori T, Pinilla-Ibarz J, Shah BD, Crowder SL, Parker NH, Carson TL, Vinci CE, Pidala JA, Logue J, Locke FL, Jim HSL. Hoogland AI, et al. Among authors: jain md. Transplant Cell Ther. 2024 Sep 19:S2666-6367(24)00666-3. doi: 10.1016/j.jtct.2024.09.013. Online ahead of print. Transplant Cell Ther. 2024. PMID: 39306278
Integrated multi-omics analysis of zinc-finger proteins uncovers roles in RNA regulation.
Gosztyla ML, Zhan L, Olson S, Wei X, Naritomi J, Nguyen G, Street L, Goda GA, Cavazos FF, Schmok JC, Jain M, Uddin Syed E, Kwon E, Jin W, Kofman E, Tankka AT, Li A, Gonzalez V, Lécuyer E, Dominguez D, Jovanovic M, Graveley BR, Yeo GW. Gosztyla ML, et al. Among authors: jain m. Mol Cell. 2024 Sep 16:S1097-2765(24)00664-6. doi: 10.1016/j.molcel.2024.08.010. Online ahead of print. Mol Cell. 2024. PMID: 39303722
Complement component 5a receptor 1 and leukotriene B4 receptor 1 regulate neutrophil extracellular trap (NET) formation through Rap1a/B-Raf/ERK signaling pathway and their deficiency in term low birth weight newborns leads to deficient NETosis.
Das D, Thacker H, Priya K, Jain M, Singh S, Rai G. Das D, et al. Among authors: jain m. Int Immunopharmacol. 2024 Sep 19;142(Pt B):113165. doi: 10.1016/j.intimp.2024.113165. Online ahead of print. Int Immunopharmacol. 2024. PMID: 39303536
4,356 results